Edition:
India

Smith & Nephew PLC (SN.L)

SN.L on London Stock Exchange

1,483.50GBp
25 Apr 2019
Change (% chg)

13.50 (+0.92%)
Prev Close
1,470.00
Open
1,475.00
Day's High
1,483.50
Day's Low
1,463.50
Volume
3,540,098
Avg. Vol
2,231,194
52-wk High
1,548.50
52-wk Low
1,242.50

About

Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip... (more)

Overall

Beta: 0.47
Market Cap(Mil.): £12,899.35
Shares Outstanding(Mil.): 875.01
Dividend: 16.82
Yield (%): --

Financials

Deals of the day-Mergers and acquisitions

March 12 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Tuesday:

13 Mar 2019

Britain's Smith & Nephew to buy Osiris in regenerative products push

Smith & Nephew Plc said on Tuesday it would buy U.S.-based regenerative medicine maker Osiris Therapeutics for $660 million, as the British medical products maker looks to bulk up in an area that is quickly growing.

12 Mar 2019

UPDATE 1-Britain's Smith & Nephew to buy Osiris in regenerative products push

March 12 Smith & Nephew Plc said on Tuesday it would buy U.S.-based regenerative medicine maker Osiris Therapeutics for $660 million, as the British medical products maker looks to bulk up in an area that is quickly growing.

12 Mar 2019

Smith & Nephew to buy Osiris Therapeutics for $660 mln

March 12 British medical products maker Smith & Nephew Plc said on Tuesday it would buy U.S.-based regenerative medicine maker Osiris Therapeutics for $660 million, as it looks to boost profit margins and find new sources of growth.

12 Mar 2019

Smith & Nephew in talks to buy NuVasive for over $3 billion: FT

Britain's Smith & Nephew Plc has held talks to buy U.S. medical equipment maker NuVasive in a deal that would be worth more than $3 billion, the Financial Times reported on Friday, citing people familiar with the talks.

09 Feb 2019

UPDATE 2-Smith & Nephew in talks to buy NuVasive for over $3 bln - FT

Feb 8 Britain's Smith & Nephew Plc has held talks to buy U.S. medical equipment maker NuVasive in a deal that would be worth more than $3 billion, the Financial Times reported on Friday, citing people familiar with the talks.

09 Feb 2019

UPDATE 1-Smith & Nephew in talks to buy NuVasive for over $3 bln - FT

Feb 8 Britain's Smith & Nephew Plc has held talks to buy U.S.-based medical equipment maker NuVasive in a deal that would be worth more than $3 billion, the Financial Times reported on Friday, citing people familiar with the talks.

09 Feb 2019

Smith & Nephew in talks to buy NuVasive for over $3 bln - FT

Feb 8 Britain's Smith & Nephew Plc has held talks to buy U.S.-based medical equipment maker NuVasive in a deal that would be worth more than $3 billion, the Financial Times reported on Friday, citing people familiar with the talks.

09 Feb 2019

CORRECTED-UPDATE 1-Emerging markets to fuel Smith & Nephew revenue growth in 2019

Feb 7 British medical products maker Smith & Nephew forecast full-year revenue growth in line with analysts' expectations on Thursday, as it looks to grow in emerging markets and expand its product line-up.

07 Feb 2019

Smith & Nephew misses on Q4 revenue as developed markets slow

Feb 7 British medical products maker Smith & Nephew fell short of analysts' expectations for fourth-quarter revenue on Thursday, as growth in established markets including the United States slowed and the company was hurt by a stronger dollar.

07 Feb 2019

Earnings vs. Estimates